Document is current
Any future updates will be listed below
-
Authors
Alsharif, Ola
Rombouts, Krista
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 1 September 2025
First Online: 1 October 2025
Competing interests
: Ola Alsharif has no conflicts of interest relevant to this article to disclose. Krista Rombouts owns shares or receives stock options in Engitix Therapeutics Ltd. and receives consultancies from Engitix Therapeutics Ltd.
